> ## Content Index
> Fetch the complete content index at: https://members.americanhealthintel.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CMS-2449-P Medicaid state-directed-payments rule hits its comment deadline
- URL: https://members.americanhealthintel.com/2026-07-21-regulator/
- Published: 2026-07-21T09:51:46.000Z
- Updated: 2026-07-21T09:51:46.000Z
- Description: Plus: NeoGenomics pays $9.8M after self-disclosing kickback-style referral arrangement. The day's rules, money, and enforcement, sourced and tiered below.
- Author: American Health Intel

Plus: NeoGenomics pays $9.8M after self-disclosing kickback-style referral arrangement. The day's rules, money, and enforcement, sourced and tiered below.

| American Health Intel Rules · Money · Medicine · Decoded daily The Regulator Tuesday, July 21, 2026 CMS-2449-P Medicaid state-directed-payments rule hits its comment deadline Plus: NeoGenomics pays $9.8M after self-disclosing kickback-style referral arrangement. The day's rules, money, and enforcement, sourced and tiered below. ![](https://americanhealthintel.com/email/pulse-divider.png) Rule Confidence: High A federal rule capping what states can pay hospitals and insurers above Medicare rates through Medicaid, the health coverage program for low-income Americans, hit its public comment deadline today. CMS-2449-P would cap Medicaid state-directed payments at 100% to 110% of Medicare rates and phase down existing above-cap payments starting 2028\. CMS projects $774.8B in savings over 10 years, $510.1B of it federal. Why it matters This rule could reshape how much money flows to hospitals and insurers through Medicaid, one of the country's largest health programs; watch for a final rule and whether the caps survive as proposed. Sources: [Federal Register](https://www.federalregister.gov/documents/2026/05/22/2026-10292/medicaid-program-medicaid-managed-care-state-directed-payments-and-medicaid-fee-for-service-targeted?ref=members.americanhealthintel.com) · [CMS](https://www.cms.gov/newsroom/press-releases/cms-moves-rein-misused-medicaid-dollars-reward-quality-care?ref=members.americanhealthintel.com) Enforcement Confidence: Low A national medical lab that reads biopsies and runs genetic tests, NeoGenomics, will pay $9.8 million after turning itself in for giving doctors' offices cut-rate perks and commissions in exchange for sending it business. The government alleged NeoGenomics gave providers below-market consulting deals and paid referral-based commissions for lab-testing referrals, an anti-kickback and physician self-referral concern. Self-disclosed to HHS in 2021. Why it matters A national lab company is paying millions after admitting it gave doctors' offices financial perks tied to referrals, a reminder that even self-reported violations carry real settlement costs. Sources: [SEC](https://www.sec.gov/Archives/edgar/data/0001077183/000107718326000045/a2026-07x20pressrelease.htm?ref=members.americanhealthintel.com) Also today PHI Health v. HCSC oral argument on enforcing a No Surprises Act arbitration award [Read](https://americanhealthintel.com/editions/2026-07-21-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#phi-health-hcsc-no-surprises-arbitration) FDA says the positive Cyclospora lab test tied to Taylor Farms was a false positive [Read](https://americanhealthintel.com/editions/2026-07-21-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#fda-cdc-cyclospora-taco-bell-lettuce-outbreak) Tennessee closes application window on its Rural Health Transformation Program grants [Read](https://americanhealthintel.com/editions/2026-07-21-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#tennessee-rural-health-transformation-grants) 191Records$16.0BEnforcement7Deadlines69Rules [Read this issue + the trackers](https://americanhealthintel.com/editions/2026-07-21-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) Pick your field on the site and every story tells you what it means for you. Reply to this email and tell us what you want covered. We read everything. We show our work. We score our own calls. [Track record](https://americanhealthintel.com/ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Calendar](https://americanhealthintel.com/calendar/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Enforcement](https://americanhealthintel.com/enforcement/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [X](https://x.com/amhealthintel?ref=members.americanhealthintel.com) · [LinkedIn](https://www.linkedin.com/company/american-health-intel?ref=members.americanhealthintel.com) News and analysis, not legal, medical, coding, or investment advice.You subscribed at americanhealthintel.com · [Unsubscribe](%%{unsubscribe%5Furl}%%) |
| ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |